Showing results (1131-1140 of 1,953) with videos related to

Sort By:
Pageof 196
Journal of Chromatography. A|March 8, 2013
Preparation and characterization of open-tubular capillary column modified with graphene oxide nanosheets for the separation of small organic moleculesYin-Yin Xu, Xiao-Ying Niu, Ya-Lei Dong, et al.
European Journal of Medical Research|July 7, 2021
Cangrelor ameliorates CLP-induced pulmonary injury in sepsis by inhibiting GPR17Qiancheng Luo, Rui Liu, Kaili Qu, et al.
Brain, Behavior, and Immunity|December 10, 2022
Adaptor protein MyD88 confers the susceptibility to stress via amplifying immune danger signalsXia-Ping Yao, Jian Ye, Ting Feng, et al.
Medicine|December 8, 2020
The association study of Apolipoprotein E polymorphisms and chronic obstructive pulmonary disease in the Chinese population: A case-control studyYuan Zhang, Xiao-Hui Li, Yu-Tian Zhou, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|October 14, 2009
Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trialJi-Zhu Liu, Shou-Guo Chen, Bin Zhang, et al.
ACS Applied Materials & Interfaces|February 3, 2021
Toward the Limitation of Dealloying: Full Spectrum Responsive Ultralow Density Nanoporous Gold for Plasmonic Photocatalytic SERSJinglin Huang, Cuilan Tang, Guo Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 13, 2007
[The correlation study of PTEN gene expression and Akt phosphorylation in myelodysplastic syndrome]Bao-Guo Chen, Min Zhu, Wen-Da Luo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 13, 2012
[Trends in the mortality of liver cancer in Qidong, China: an analysis of fifty years]Jian-guo Chen, Jian Zhu, Yong-hui Zhang, et al.
Oncology Reports|June 30, 2018
Genome‑wide profiling of lncRNA expression patterns in patients with acute promyelocytic leukemia with differentiation therapyJian Yu, Xiao-Ling Guo, Yuan-Yuan Bai, et al.
Anti-Cancer Drugs|February 2, 2023
Novel third-generation tyrosine kinase inhibitor for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a case studyXu Tan, Qin Wen, Guo Chen, et al.
Pageof 196